AAS
HALO icon

Ameritas Advisory Services’s Halozyme HALO Stock Holding History

Ameritas Advisory Services’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,189
Closed -$400K – 2040
2026
Q1 		$400K Buy
6,189
+535
+9% +$37.7K 0.02% 660
2025
Q4 		$381K Buy
+5,654
New +$380K 0.01% 669

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ameritas Advisory Services's HALO Position: Q2 2026 in Review

Ameritas Advisory Services sold out of Halozyme (HALO) in Q2 2026, closing a stake of 6,189 shares — an estimated $400K sold.

Ameritas Advisory Services first reported a position in HALO in Q4 2025 and held it in 2 quarters. The position peaked at $400K in Q1 2026. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Ameritas Advisory Services reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Ameritas Advisory Services sold 6,189 Halozyme shares in Q2 2026, an estimated $400K.
  • Ameritas Advisory Services first reported a position in Halozyme in Q4 2025 and held it in 2 quarters.
  • Ameritas Advisory Services's Halozyme position peaked at $400K in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.